Year All 2026 2025 2024 2023 2022 2021 2020 Helus Pharma Highlights Clinical Program Advancements at Investor Presentation Held on October 21, 2026 October 21, 2026 Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors October 15, 2026 Helus Pharma to Host Investor Presentation on October 21, 2026 October 8, 2026 Helus Pharma Announces Completion of Legal Name Change October 1, 2026 Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change September 22, 2026 Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit September 21, 2026 Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026 September 21, 2026 Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York September 10, 2026 Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York September 9, 2026 Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York September 3, 2026
Helus Pharma Highlights Clinical Program Advancements at Investor Presentation Held on October 21, 2026 October 21, 2026
Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change September 22, 2026
Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit September 21, 2026
Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026 September 21, 2026
Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York September 10, 2026
Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York September 9, 2026
Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York September 3, 2026
